Skip to main content
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple Myeloma
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple Myeloma
User login
Username
Password
Reset your password
Concept
Lead
score
Multiple Myeloma
1
1
Proteasome Inhibitor
0
0.75
Neuropathy
0
0.6
Toxicology
0
0.56
Biologic Therapy
0
0.51
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.81
Emergency Medicine
0
0.56
Public Health & Prevention
0
0.56
Allergy & Clinical Immunology
0
0.51
Edit Tags